[HTML][HTML] Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic …

JW Jung, HS Park, CS Park, SH Cho… - The Korean journal of …, 2021 - ncbi.nlm.nih.gov
Methods This study was conducted as a multicenter, single-group, open trial to evaluate the
improvement in the quality of life with the additional administration of omalizumab for 24 …

[PDF][PDF] Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab

D Ediger, F Esra - Tuberk Toraks, 2023 - researchgate.net
Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life
experience with omalizumab Introduction: Omalizumab, a humanized monoclonal anti-IgE …

Futuras terapias biológicas en el asma

S Quirce, I Bobolea, J Domínguez-Ortega… - Archivos de …, 2014 - Elsevier
Un porcentaje elevado de pacientes con asma no está controlado, incluso a pesar de seguir
un tratamiento adecuado. Esto indica que son necesarios tratamientos alternativos que …

Current and future asthma treatments: phenotypical approach on the path to personalized medicine in asthma

ID Bobolea, C Melero… - … CHILDHOOD ASTHMA to …, 2016 - books.google.com
Despite widely available and effective treatments, achieving asthma control is still an unmet
need for many patients. One of the explanations resides perhaps in the heterogeneity of the …

Универсальная информационная структура как инструмент длительного динамического мониторинга в аллергологии

ЕА Вишнёва, ЛС Намазова-Баранова… - Педиатрическая …, 2014 - cyberleninka.ru
Статья посвящена проблеме организации длительного динамического наблюдения
популяции пациентов в условиях реальной клинической практики. Каждое медицинское …

Current and future asthma therapies.

M Kandeel, M Balaha, N Inagaki… - Drugs of Today …, 2013 - europepmc.org
Corticosteroids (CST) are the gold standard for asthma management and for several
decades have been considered the cornerstone for asthma control. With the recent advent of …

Registries as useful tools in characterization of allergic manifestations

EJ Jares, HA Badellino, LF Ensina - Current Opinion in Allergy and …, 2016 - journals.lww.com
Registries as useful tools in characterization of allergic m... : Current Opinion in Allergy and
Clinical Immunology Registries as useful tools in characterization of allergic manifestations …

Targeting immunoglobulin E in non-atopic asthma: crossing the red line?

M Gaga, E Zervas, M Humbert - European Respiratory Journal, 2016 - Eur Respiratory Soc
Asthma is a heterogeneous disease on a clinical as well as a mechanistic level. A major
molecular mechanism of asthma is considered to be driven by type 2 T-helper cells (Th2) …

Comparison of allergic asthma patients treated with omalizumab and non-allergic patients treated with continuous oral corticosteroids: results of five year follow-up …

B Gemicioğlu, B Duman - Tuberkuloz ve Toraks, 2016 - europepmc.org
Comparison of allergic asthma patients treated with omalizumab and non-allergic patients
treated with continuous oral corticosteroids: results of five year follow-up therapies. - Abstract …

Defining severe asthma–an approach to find new therapies

AM Nanzer, A Menzies-Gow - European Clinical Respiratory …, 2014 - Taylor & Francis
Asthma is a chronic inflammatory disease that has reached epidemic proportions worldwide.
It is treatable in the majority of patients, but there is no cure. Moreover, a proportion of …